We are a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on our T-win technology platform. Our product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. We believe this represents a paradigm shift in the management of cancer and that our product candidates have the […]

We intend to focus our search on companies with operations in the vision sensing technologies (“VST”), including hardware chip solutions (such as chips, modules and systems), VST-related application software, artificial intelligence (“AI”) and other peripheral technologies that assist to integrate and/or supplement VST applications. There is no restriction in the geographic location of targets we […]

We intend to initially focus our search on identifying a prospective target business in the technology industries in the United States and other developed countries, with a special focus within the space technology, financial technology, technology, media and telecom (“TMT”) industries and related sectors. Though our sponsor is a Hong Kong company, a majority of our management […]

All of our products are prepared with proprietary ingredient systems that allow us to provide consumers with delicious meals that are designed to be high in protein, low in sugar, and made with gluten- and grain-free ingredients. Our base ingredient systems, which include (i) chicken and parmesan cheese, and (ii) plant-based proteins and fibers, are composed of […]

We are a molecular genetics cancer diagnostic company formed in 2021 to acquire PharmGenomics GmbH (“PharmGenomics“) with the purpose of commercializing their product portfolio in Europe and the United States. PharmGenomics has developed several IVD tests for the European market since it was founded in 2008. Our portfolio includes ColoAlert, a colorectal cancer (“CRC”) screening stool DNA […]

(Note: Desert Peak Minerals withdrew its IPO in a letter to the SEC dated Jan. 12, 2022; the company had postponed its IPO on the afternoon of Nov. 4, 2021, just hours ahead of the expected pricing.) We acquire, own and manage mineral and royalty interests in the Permian Basin with the objective of generating […]

We are a leading online real estate classifieds platform in the large, underpenetrated and growing Russian real estate classifieds market, ranking among the top 10 most popular online real estate classifieds globally, based on September 2021 Google Analytics traffic data for Cian and SimilarWeb traffic data for other online real estate classifieds. Since our founding […]

(This is NOT an IPO. This is an uplift to the NASDAQ from the Euronext Brussels.) (Note: MDxHealth SA describes this offering as “our IPO of American Depositary Shares (“ADSs”) in the United States. We are offering 3,750,000 American Depositary Shares (“ADSs”) through the underwriters named in this prospectus, assuming a sale price of $13.46 per ADS, the […]

We intend to capitalize on our management team’s experience and expertise to identify attractive acquisition opportunities in the biopharmaceutical sector, with a focus on disruptive technologies with the potential to transform healthcare and dramatically improve the lives of patients. Our sponsor is a newly formed Delaware limited liability company. We believe our ability to complete […]

We intend to focus our efforts on businesses that leverage our management team’s experience in acquiring and operating businesses that are involved in renewable energy or related clean technology, which we refer to as the alternative energy sector. We intend to focus on the significant opportunities we believe will result from the ongoing transformation of […]